Literature DB >> 2760168

Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle.

W D Odell1, J Griffin.   

Abstract

Several groups of investigators have previously reported that small amounts of hCG are present in blood and urine of nonpregnant eugonadal women and men. We have developed highly sensitive and specific, two-monoclonal antibody, sandwich-type assays which can quantify both hCG and LH in sera from postmenopausal women, women at all phases of the menstrual cycle, and men. Using these assays we have also reported that hCG is secreted in a pulsatile fashion in postmenopausal women, is stimulated by GnRH in both men and postmenopausal women, and is suppressed by a GnRH agonist in castrate men. Employing these same sandwich assays, we report herein that hCG is secreted in a pulsatile manner during the follicular and luteal phases of the normal menstrual cycle. During the follicular phase 0.68 +/- 09 (+/- SEM) pulses of hCG occurred each hour, while 0.62 +/- 0.08 pulses of LH occurred. Pulse durations during the follicular phase for hCG and LH, respectively, were 38.3 +/- 4.4 and 62.5 +/- 11.1 min (P less than or equal to 0.05). During the luteal phase there were 0.42 +/- 0.16 pulses/h of hCG and 0.38 +/- 0.08 pulses of LH (P greater than 0.05). Pulse durations were 22.3 +/- 7.5 and 126.4 +/- 19.0 min for hCG and LH, respectively (P less than 0.01). The t1/2 of hCG disappearance was 37.2 +/- 3.8 min during the follicular phase and 22.9 +/- 4.6 min during the luteal phase. The t1/2 values of LH were 82.9 +/- 5.7 and 67.5 +/- 5.12 min during follicular and luteal phases, respectively. The t1/2 of LH was greater than the t1/2 of hCG (P less than 0.01). We conclude that small amounts of hCG are secreted in a pulsatile manner during follicular and luteal phases of the human menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760168     DOI: 10.1210/jcem-69-3-528

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  HCG variants, the growth factors which drive human malignancies.

Authors:  Laurence A Cole
Journal:  Am J Cancer Res       Date:  2011-11-20       Impact factor: 6.166

2.  Requirements for human chorionic gonadotropin and recombinant human luteinizing hormone for follicular development and maturation.

Authors:  C Y Andersen; S Ziebe; X Guoliang; A G Byskov
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

3.  Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.

Authors:  Q Qiu; J W Overstreet; H Todd; S T Nakajima; D R Stewart; B L Lasley
Journal:  Environ Health Perspect       Date:  1997-08       Impact factor: 9.031

4.  CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism.

Authors:  Aleksandra Głodek; Anna Jankowska
Journal:  Tumour Biol       Date:  2014-02-20

Review 5.  Human chorionic gonadotropin-like proteins: secretion in nonpregnant humans and production by bacteria.

Authors:  W D Odell; J Griffin; S Grover; D T Carrell
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 6.  Biological functions of hCG and hCG-related molecules.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2010-08-24       Impact factor: 5.211

Review 7.  A rational diagnostic approach to the "phantom hCG" and other clinical scenarios in which a patient is thought to be pregnant but is not.

Authors:  Oluwafunmilayo Oyatogun; Mandeep Sandhu; Stephanie Barata-Kirby; Erin Tuller; Danny J Schust
Journal:  Ther Adv Reprod Health       Date:  2021-06-13

Review 8.  Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.

Authors:  Janet Choi; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2013-11-27       Impact factor: 2.260

9.  First-in-human trial assessing the pharmacokinetic-pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age.

Authors:  Lars-Erik Broksø Kyhl; Christiane Hesse; Per Larsson; Katharina Bruzelius; Bernadette Mannaerts
Journal:  Clin Transl Sci       Date:  2021-06-21       Impact factor: 4.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.